Brain protection in schizophrenia, mood and cognitive disorders /

Saved in:
Bibliographic Details
Imprint:Dordrecht ; London : Springer, c2010.
Description:1 online resource (xv, 663 p.) : ill.
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/8893316
Hidden Bibliographic Details
Other authors / contributors:Ritsner, Michael S.
ISBN:9789048185535
904818553X
9789048185528 (electronic bk.)
9048185521 (electronic bk.)
Notes:Includes bibliographical references and index.
Description based on print version record.
Summary:Neuroprotection is a novel perspective for the treatment of disorders that lead to neurodegeneration and disabilities as a result of deterioration of neurons due to apoptosis, oxidative stress, excitotoxicity, and other mechanisms. These mechanisms have implications not only for neurodegenerative disorders, but also for schizophrenia, mood and cognitive disorders. The purpose of this book is to provide an up-to-date overview of basic and clinical studies concerning the neuroprotective approach, mechanisms, and several compounds with neuroprotective properties that may contribute to more effica.
Other form:Print version: Brain protection in schizophrenia, mood and cognitive disorders. Dordrecht ; London : Springer, c2010 9789048185528 9048185521

MARC

LEADER 00000cam a2200000Ia 4500
001 8893316
003 ICU
005 20120829131100.0
006 m d
007 cr cn|
008 100810s2010 ne a ob 001 0 eng d
019 |a 654363148  |a 746533477 
020 |a 9789048185535 
020 |a 904818553X 
020 |a 9789048185528 (electronic bk.) 
020 |a 9048185521 (electronic bk.) 
035 |a (OCoLC)654397120  |z (OCoLC)654363148  |z (OCoLC)746533477 
037 |a 978-90-481-8552-8  |b Springer  |n http://www.springerlink.com 
040 |a GW5XE  |b eng  |c GW5XE  |d TPH  |d EBLCP  |d OCLCQ  |d E7B  |d OCLCQ  |d QE2  |d MHW  |d N$T 
049 |a CGUA 
060 4 |a WM 203 
072 7 |a MED  |x 105000  |2 bisacsh 
072 7 |a PSY  |x 022000  |2 bisacsh 
072 7 |a PSY  |x 007000  |2 bisacsh 
072 7 |a PSY  |x 018000  |2 bisacsh 
072 7 |a MED  |x 102000  |2 bisacsh 
082 0 4 |a 616.89  |2 22 
090 |a RC514  |b .B73 2010 
245 0 0 |a Brain protection in schizophrenia, mood and cognitive disorders /  |c Michael S. Ritsner, editor. 
260 |a Dordrecht ;  |a London :  |b Springer,  |c c2010. 
300 |a 1 online resource (xv, 663 p.) :  |b ill. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a computer  |b c  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/c 
338 |a online resource  |b cr  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/cr 
504 |a Includes bibliographical references and index. 
588 |a Description based on print version record. 
505 0 |a Foreword; Contents; Contributors; Part I Neuroprotective Strategies and Mechanisms; 1 Brain Protection in Neuropsychiatric Disorders: Past, Present and Future Challenges; 2 Towards a New Paradigm in Neuroprotection and Neuroplasticity; 3 What Protects Patients with Schizophrenia from Developing Alzheimer Pathology?; 4 Assessing In Vivo Neurodegeneration in Schizophrenia Using Magnetic Resonance; 5 Vulnerability of the Brain to Neuropsychiatric Disorders Resulting from Abnormal Thyroid Hormone or Vitamin D Homeostasis. 
520 |a Neuroprotection is a novel perspective for the treatment of disorders that lead to neurodegeneration and disabilities as a result of deterioration of neurons due to apoptosis, oxidative stress, excitotoxicity, and other mechanisms. These mechanisms have implications not only for neurodegenerative disorders, but also for schizophrenia, mood and cognitive disorders. The purpose of this book is to provide an up-to-date overview of basic and clinical studies concerning the neuroprotective approach, mechanisms, and several compounds with neuroprotective properties that may contribute to more effica. 
650 0 |a Schizophrenia  |x Chemotherapy.  |0 http://id.loc.gov/authorities/subjects/sh85118163 
650 0 |a Affective disorders  |x Chemotherapy. 
650 0 |a Cognition disorders  |x Chemotherapy. 
650 0 |a Neuroprotective agents.  |0 http://id.loc.gov/authorities/subjects/sh2007004834 
650 1 2 |a Schizophrenia  |x drug therapy. 
650 2 2 |a Mood Disorders  |x drug therapy. 
650 2 2 |a Cognition Disorders  |x drug therapy. 
650 2 2 |a Neuroprotective Agents. 
650 4 |a Medicine. 
655 4 |a Electronic books. 
650 7 |a Affective disorders  |x Chemotherapy.  |2 fast  |0 http://id.worldcat.org/fast/fst00798862 
650 7 |a Neuroprotective agents.  |2 fast  |0 http://id.worldcat.org/fast/fst01743401 
650 7 |a Schizophrenia  |x Chemotherapy.  |2 fast  |0 http://id.worldcat.org/fast/fst01106753 
650 7 |a MEDICAL  |x Psychiatry  |x General.  |2 bisacsh 
650 7 |a PSYCHOLOGY  |x Psychopathology  |x General.  |2 bisacsh 
650 7 |a PSYCHOLOGY  |x Clinical Psychology.  |2 bisacsh 
650 7 |a PSYCHOLOGY  |x Mental Illness.  |2 bisacsh 
650 7 |a MEDICAL  |x Mental Health.  |2 bisacsh 
700 1 |a Ritsner, Michael S.  |0 http://id.loc.gov/authorities/names/nb2007021481  |1 http://viaf.org/viaf/49546172 
776 0 8 |i Print version:  |t Brain protection in schizophrenia, mood and cognitive disorders.  |d Dordrecht ; London : Springer, c2010  |z 9789048185528  |z 9048185521  |w (OCoLC)471803536 
856 4 0 |u http://dx.doi.org/10.1007/978-90-481-8553-5  |y SpringerLink 
903 |a HeVa 
035 |a (ICU)8893316 
929 |a eresource 
999 f f |i 70577944-e5e9-5199-a73f-176dccb90d5e  |s 5482ff16-9406-55f2-9a6e-26bd7abf8a00 
928 |t Library of Congress classification  |a RC514 .B73 2010  |l Online  |c UC-FullText  |u http://dx.doi.org/10.1007/978-90-481-8553-5  |z SpringerLink  |g ebooks  |i 11473075